The big picture on nanomedicine

The state of investigational and approved nanomedicine products

Research output: Contribution to journalReview article

507 Citations (Scopus)

Abstract

Developments in nanomedicine are expected to provide solutions to many of modern medicine's unsolved problems, so it is no surprise that the literature contains many articles discussing the subject. However, existing reviews tend to focus on specific sectors of nanomedicine or to take a very forward-looking stance and fail to provide a complete perspective on the current landscape. This article provides a more comprehensive and contemporary inventory of nanomedicine products. A keyword search of literature, clinical trial registries, and the Web yielded 247 nanomedicine products that are approved or in various stages of clinical study. Specific information on each was gathered, so the overall field could be described based on various dimensions, including FDA classification, approval status, nanoscale size, treated condition, nanostructure, and others. In addition to documenting the many nanomedicine products already in use in humans, this study indentifies several interesting trends forecasting the future of nanomedicine. From the Clinical Editor: In this one of a kind review, the state of nanomedicine commercialization is discussed, concentrating only on nanomedicine-based developments and products that are either in clinical trials or have already been approved for use.

Original languageEnglish (US)
Pages (from-to)1-14
Number of pages14
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Nanomedicine
Medical nanotechnology
Clinical Trials
Modern 1601-history
Nanostructures
Medicine
Registries
Equipment and Supplies

Keywords

  • Biomedical nanotechnology
  • Clinical trials
  • Human subjects research
  • Nanobiotechnology
  • Nanomedicine

Cite this

@article{0af8dcac1dc543dd8b306ff4f2c4cb93,
title = "The big picture on nanomedicine: The state of investigational and approved nanomedicine products",
abstract = "Developments in nanomedicine are expected to provide solutions to many of modern medicine's unsolved problems, so it is no surprise that the literature contains many articles discussing the subject. However, existing reviews tend to focus on specific sectors of nanomedicine or to take a very forward-looking stance and fail to provide a complete perspective on the current landscape. This article provides a more comprehensive and contemporary inventory of nanomedicine products. A keyword search of literature, clinical trial registries, and the Web yielded 247 nanomedicine products that are approved or in various stages of clinical study. Specific information on each was gathered, so the overall field could be described based on various dimensions, including FDA classification, approval status, nanoscale size, treated condition, nanostructure, and others. In addition to documenting the many nanomedicine products already in use in humans, this study indentifies several interesting trends forecasting the future of nanomedicine. From the Clinical Editor: In this one of a kind review, the state of nanomedicine commercialization is discussed, concentrating only on nanomedicine-based developments and products that are either in clinical trials or have already been approved for use.",
keywords = "Biomedical nanotechnology, Clinical trials, Human subjects research, Nanobiotechnology, Nanomedicine",
author = "Etheridge, {Michael L.} and Campbell, {Stephen A.} and Erdman, {Arthur G.} and Haynes, {Christy L.} and Wolf, {Susan M.} and Jeffrey McCullough",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.nano.2012.05.013",
language = "English (US)",
volume = "9",
pages = "1--14",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The big picture on nanomedicine

T2 - The state of investigational and approved nanomedicine products

AU - Etheridge, Michael L.

AU - Campbell, Stephen A.

AU - Erdman, Arthur G.

AU - Haynes, Christy L.

AU - Wolf, Susan M.

AU - McCullough, Jeffrey

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Developments in nanomedicine are expected to provide solutions to many of modern medicine's unsolved problems, so it is no surprise that the literature contains many articles discussing the subject. However, existing reviews tend to focus on specific sectors of nanomedicine or to take a very forward-looking stance and fail to provide a complete perspective on the current landscape. This article provides a more comprehensive and contemporary inventory of nanomedicine products. A keyword search of literature, clinical trial registries, and the Web yielded 247 nanomedicine products that are approved or in various stages of clinical study. Specific information on each was gathered, so the overall field could be described based on various dimensions, including FDA classification, approval status, nanoscale size, treated condition, nanostructure, and others. In addition to documenting the many nanomedicine products already in use in humans, this study indentifies several interesting trends forecasting the future of nanomedicine. From the Clinical Editor: In this one of a kind review, the state of nanomedicine commercialization is discussed, concentrating only on nanomedicine-based developments and products that are either in clinical trials or have already been approved for use.

AB - Developments in nanomedicine are expected to provide solutions to many of modern medicine's unsolved problems, so it is no surprise that the literature contains many articles discussing the subject. However, existing reviews tend to focus on specific sectors of nanomedicine or to take a very forward-looking stance and fail to provide a complete perspective on the current landscape. This article provides a more comprehensive and contemporary inventory of nanomedicine products. A keyword search of literature, clinical trial registries, and the Web yielded 247 nanomedicine products that are approved or in various stages of clinical study. Specific information on each was gathered, so the overall field could be described based on various dimensions, including FDA classification, approval status, nanoscale size, treated condition, nanostructure, and others. In addition to documenting the many nanomedicine products already in use in humans, this study indentifies several interesting trends forecasting the future of nanomedicine. From the Clinical Editor: In this one of a kind review, the state of nanomedicine commercialization is discussed, concentrating only on nanomedicine-based developments and products that are either in clinical trials or have already been approved for use.

KW - Biomedical nanotechnology

KW - Clinical trials

KW - Human subjects research

KW - Nanobiotechnology

KW - Nanomedicine

UR - http://www.scopus.com/inward/record.url?scp=84871404093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871404093&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2012.05.013

DO - 10.1016/j.nano.2012.05.013

M3 - Review article

VL - 9

SP - 1

EP - 14

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 1

ER -